Unique ID issued by UMIN | UMIN000034173 |
---|---|
Receipt number | R000038962 |
Scientific Title | The efficacy of Clostridium butyricum products (Miya-BM) on urinary tract infections among the patients with long-term urethral catheterization |
Date of disclosure of the study information | 2018/09/18 |
Last modified on | 2021/03/24 16:07:13 |
The efficacy of Clostridium butyricum products (Miya-BM) on urinary tract infections among the patients with long-term urethral catheterization
The efficacy of Clostridium butyricum products among patients with urethral catheterization
The efficacy of Clostridium butyricum products (Miya-BM) on urinary tract infections among the patients with long-term urethral catheterization
The efficacy of Clostridium butyricum products among patients with urethral catheterization
Japan |
Patients with long-term urethral catheterization for more than 3 months
Urology |
Others
NO
To evaluate prospectively efficacy of Clostridium butyricum products for chronic urinary tract infections among patients with long-term urethral catheterization
Efficacy
Others
Pragmatic
Not applicable
Any troubles and symptoms by urethral catheter
Symptomatic UTIs, necessity of antibiotic treatment, urinalysis, urine culture, stool culture
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1)20 years and over
2)Patients with urethral catheterization for more than 3 months, and who are required to continue it in the future
3)Patients planning to administer Clostridium butyricum products for Defecation disorders
Patients who have any of the following conditions are excluded.
1)Patients who have difficulty in oral administration of Clostridium butyricum products (Administration of drugs from gastrostomy or gastric tube is acceptable for inclusion)
2)Patients who provided written informed consent regarding study participation from themselves or their family.
3)Patients who judged by the investigator as ineligibility for entry
4)Patients with administrations of any antibiotics within one month.
50
1st name | Kazuyoshi |
Middle name | |
Last name | Kazuyoshi |
Kanazawa University Graduate School of Medical Science
Department of Integrative Cancer Therapy and Urology
920-8641
13-1 Takaramachi Kanazawa Ishikawa Japan
076-265-2393
Kshigehara0415@yahoo.co.jp
1st name | Kazuyoshi |
Middle name | |
Last name | Kazuyoshi |
Kanazawa University Graduate School of Medical Science
Department of Integrative Cancer Therapy and Urology
920-8641
13-1 Takaramachi Kanazawa Ishikawa Japan
076-265-2393
Kshigehara0415@yahoo.co.jp
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science
None
Other
Innovative Clinical Research Center, Kanazawa University
13-1, Takaramachi, Kanazawa, Ishikawa
076-265-2000
crc.irb-knz@esct.jp
NO
金沢大学医薬保健研究域 医学系泌尿器集学的治療学(金沢大学附属病院 泌尿器科)
2018 | Year | 09 | Month | 18 | Day |
Unpublished
Enrolling by invitation
2018 | Year | 06 | Month | 30 | Day |
2018 | Year | 08 | Month | 22 | Day |
2018 | Year | 09 | Month | 21 | Day |
2022 | Year | 03 | Month | 31 | Day |
2022 | Year | 09 | Month | 30 | Day |
2022 | Year | 12 | Month | 31 | Day |
2023 | Year | 03 | Month | 31 | Day |
To evaluate efficacy of Clostridium butyricum products on incidences of any troubles by urethral catherter and symptomatic urinary tract infection. Observation is 3 months. Currently, 21 cases were included in this study.
2018 | Year | 09 | Month | 17 | Day |
2021 | Year | 03 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038962